Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Alternative payment tools emerge as mainstream for e-commerce payments in APAC, finds GlobalData

Alternative payments have gained significant prominence among online shoppers in the Asia-Pacific (APAC) region with payment solutions such as mobile and digital wallets displacing traditional payment methods like cash and cards, says GlobalData, a leading data and analytics company. According to GlobalData’s E-Commerce Analytics, e-commerce payments in APAC (covering 16 countries) are estimated to increase […]
Read more

Deloitte emerges as leader among big four consulting firms on social media in 2021, finds GlobalData

Deloitte Touche Tohmatsu Limited (Deloitte) turned up as the most mentioned company among the big four consulting firms on basis of social media conversations of Twitter Influencers and Redditors in 2021*, according to GlobalData, a leading data and analytics company. GlobalData’s Social Media Analytics (SMA) Platform, which identifies and tracks the emerging trends, pain areas, […]
Read more

Enterprise spending on data center and hosting services in China to grow at 6.8% CAGR through 2025, forecasts GlobalData

The total addressable market size of the data center and hosting services in China, in terms of enterprise spending opportunity, is set to increase at a CAGR of 6.8% between 2020 and 2025, driven by rising demand for storage and computing power among enterprises that can support technology infrastructure upgrades and online/digital service implementations, says […]
Read more

Chinese pharma companies eye strategic alliances to bring innovative siRNA-based therapeutics, observes GlobalData

The overall potential of siRNA-based therapeutics has attracted Chinese pharma companies to tap opportunities and bring promising innovative therapies across the globe. Against this backdrop, the Chinese pharma companies have increased their focus towards the siRNA pipeline through strategic alliances*, finds GlobalData, a leading data and analytics company. China pharma companies have executed four deals […]
Read more

Vascular embolization plugs and coils market in Japan to grow at 3% CAGR through 2030, says GlobalData

The vascular embolization plugs and coils market in Japan is expected to grow at a compound annual growth rate (CAGR) of 3% through 2030, driven by growing preference for endovascular minimally invasive procedures over traditional surgeries, forecasts GlobalData, a leading data, and analytics company. GlobalData’s latest report, “Vascular Embolization Plugs and Coils (Cardiovascular) – Global […]
Read more

Engineering Microorganisms into Powerful Micromachines

#SyntheticBiology (#SynBio) has the potential to solve a wide range of global needs through breakthroughs in #Bioproduction, #Biosensing, #ClosedLoopMedicines, #CropProtection, and #ProbioticDelivery. An analysis of GlobalData Plc #Disruptor #Deals database reveals that SynBio #VentureCapital (#VC) deals have surged over the past two years. Reportedly low-cost #Biomanufacturing and #DNAsequencing methods have piqued the interest of investors in exploring SynBio’s potential applications in #FoodManufacturing and #Pharmaceuticals. In fact, the total VC funding has surpassed $4bn by […]
Read more

Indian pharma companies gearing up to grab opportunities in global supply of oral COVID-19 drugs, observes GlobalData

Indian pharma companies have already occupied pole position in the supply of repurposed COVID-19 drugs globally. With the launch of new innovative COVID-19 oral drugs, Indian companies are again expected to grab opportunities in the global supply of oral COVID-19 drugs, says GlobalData, a leading data and analytics company. Several countries are observing increasing cases […]
Read more

Innovative therapeutic classes to drive NMOSD market in China at 20.9% CAGR through 2030, forecasts GlobalData

The neuromyelitis optica spectrum disorder (NMOSD) therapeutics market is highly genericized, with corticosteroids and immunosuppressants currently accounting for the highest portion of prescribed drugs in China. However, the introduction of more innovative and effective classes of therapies is expected to drive increasing sales through 2030 at a compound annual growth rate (CAGR) of 20.9%, according […]
Read more

Can Synthetic Biology Foster Bio-Revolution

Achieving global goals such as mass-scale #food production and #sustainable low-cost #manufacturing methods is the need of the hour. Synthetic Biology (SynBio) is a field of #science that has grown over the last two decades to emerge as a mature area in #biologicalengineering with its potential to reduce the #costs of biological production methods and improve the global food #supply. It also can be crucial to create #patient-centric #drugs and promote #precisionmedicine for […]
Read more

R&D-as-a-service model breathes new life into synthetic biology revolution, says GlobalData

Synthetic biology companies are spreading their wings across industries by embracing transformative business models. One such model is R&D-as-a-service (RDaaS), which is offering significant growth to synthetic biology companies to fabricate outcome-oriented products in multiple industries, says GlobalData, a leading data and analytics company. Sanchari Chatterjee, Disruptive Tech Analyst at GlobalData, comments: “Instead of targeting […]
Read more

Malaysia e-commerce market to grow by 10.6% in 2021, reveals GlobalData

The Malaysian e-commerce market, one of the fastest growing in the Southeast Asia, is expected to register a strong growth of 10.6% in 2021 due to an accelerated shift towards online shopping among consumers caused by the COVID-19 pandemic, forecasts GlobalData, a leading data and analytics company. Nikhil Reddy, Payments Senior Analyst at GlobalData, comments: […]
Read more
1 … 150 151 152 153 154 … 209